Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT06992934
Eligibility Criteria:
Inclusion Criteria:
* Patient \> 18y/o
* Patient who received an allogeneic stem cell transplantation for an acute myeloid leukemia and who will receive gilteritinib as post transplantation maintenance
* Matched related, matched unrelated, mismatched unrelated and haploidentical donors
Exclusion Criteria:
* Minors
* Pregnant women
* Patient under 'tutelle', 'curatelle' or in prison
* Patient who has been treated for a solid tumor in the past 2 years
* Known human immunodeficiency virus (HIV) infection or HIV-related malignancy
* Clinically active hepatitis B or hepatitis C infection
* Known allergy or hypersensitivity to gilteritinib
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06992934
Study Brief:
Protocol Section:
NCT06992934